M&T Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
M&T Bank's BMY Position: Q1 2026 in Review
M&T Bank reduced its Bristol-Myers Squibb (BMY) stake by 0.63% in Q1 2026, selling an estimated $283K and leaving 771,822 shares worth $46.8M. The position accounts for 0.16% of the portfolio, ranked #114.
M&T Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $120M in Q2 2015. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- M&T Bank held 771,822 shares of Bristol-Myers Squibb worth $46.8M as of Q1 2026.
- M&T Bank sold 4,861 Bristol-Myers Squibb shares in Q1 2026, an estimated $283K.
- Bristol-Myers Squibb made up 0.16% of M&T Bank's portfolio in Q1 2026, its #114 holding.
- M&T Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- M&T Bank's Bristol-Myers Squibb position peaked at $120M in Q2 2015.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.